Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 4, 2013

ARCA biopharma, Astellas, BioMarin, Immunomedics, Medivation, OncoMed, RXi, Senesco

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I OncoMed begins pancreatic cancer trial . . . read more RXi to advance CTGF scar treatment . . . read more Senesco completes third cohort in myeloma trial . . . read more Phase II Medivation, Astellas begin breast cancer trial . . . read more Filings ARCA IND approved for AF study . . . read more BioMarin submits Vimizim in Canada . . . read more Immunomedics ADC gets Orphan status . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters